Lung Cancer Clinical Trial
Official title:
Epidemiology and Psychosocial Evaluation of Inpatient With Lung Opacity :a Prospective Multicentre Study
Lung cancer is one of the leading cause of cancer related death in China.Different from
patients in the US, Chinese patients with lung nodules tend to be less related to smoking,
and seem to be more willing to get operation despite of the doctors' suggestion of imaging
surveillance.
This study is designed to figure out the risk factors for Chinese lung cancer patients and
evaluate the psychosocial status of inpatients with lung nodules.
Smoking is the only determinate risk factor proposed by the NCCN(National Comprehensive
Cancer Network) Clinical Practice Guidelines for lung cancer screening. However, it has been
estimated that over half of Chinese female lung cancer patients are non-smokers. Thus it
might be reasonable to take unique Chinese cooking habit and environment pollution into
consideration when it comes to the risk factors for lung cancer in Chinese people.
Lung nodules are reported to exist in 25-70% patients who have undergone LDCT (Low-dose
Computed Tomography)examination. However, the prevalence of malignant nodules is reported to
be 1.1-3% by different researchers. Even in country with comprehensive medical consulting
system and lung nodule management consensus, almost all patients assume their lung nodules to
be malignant when detected by LDCT for the first time.The investigators noticed nearly 1/3 of
the inpatients are determined to get operation despite the surgeons' suggestion of CT
surveillance according to the NCCN guideline in Department of Thoracic surgery in Peking
University People's Hospital. As there's no evidence suggesting lung nodules in Chinese
people have more possibility of malignancy, the investigators would like to know whether
those patients who choose to get operation "ahead of the guideline" has higher level of
cancer distress, and figure out whether psychosocial factors should be taken into
consideration of lung nodules management when living with an indeterminate tumor has added up
to patients' negative emotion and reduced their quality of life.
The investigators do the survey on the first day of admission during the inpatient education,
help patients fill in the questionnaire including personal information, smoking history,
medical history, their diet and lifestyle habits, family history of malignant neoplasm, any
past or current environmental exposures and psychological status.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|